Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion.
about
Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Cost-effectiveness of screenin ...... to urinary albumin excretion.
@en
Cost-effectiveness of screenin ...... to urinary albumin excretion.
@nl
type
label
Cost-effectiveness of screenin ...... to urinary albumin excretion.
@en
Cost-effectiveness of screenin ...... to urinary albumin excretion.
@nl
prefLabel
Cost-effectiveness of screenin ...... to urinary albumin excretion.
@en
Cost-effectiveness of screenin ...... to urinary albumin excretion.
@nl
P2093
P2860
P356
P1476
Cost-effectiveness of screenin ...... d to urinary albumin excretion
@en
P2093
Antonia Vlahou
Elena Critselis
Vianda S Stel
P2860
P304
P356
10.1093/NDT/GFX068
P407
P577
2018-03-01T00:00:00Z